SCHEMBL21362323

SCHEMBL21362323

CN1C=CN(c2cccc(Oc3cc(Oc4ccccn4)cc4c3oc3ccccc34)c2)C1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.38
NPC1 O15118 1/20 0.38
FFAR4 Q5NUL3 2/20 0.37
PTGS2 P35354 2/20 0.36
GRM5 P41594 1/20 0.35
LMNA P02545 2/20 0.35
USP2 O75604 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
TLR4 O00206 1/20 0.34
TLR2 O60603 1/20 0.34
GCK P35557 1/20 0.32
PPARG P37231 1/20 0.31
DRD4 P21917 1/20 0.30
IP6K1 Q92551 1/20 0.30
IP6K3 Q96PC2 1/20 0.30
IP6K2 Q9UHH9 1/20 0.30
LTA4H P09960 1/20 0.30
SCN7A Q01118 1/20 0.30
KCNH2 Q12809 1/20 0.30
CSF1R P07333 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21362370 0.92 MAPT (0.36) MAPTNPC1FFAR4PTGS2GRM5
SCHEMBL21362374 0.85 NPC1 (0.39) MAPTNPC1FFAR4PTGS2GRM5
SCHEMBL21362289 0.83 PTGS2 (0.34) MAPTNPC1FFAR4PTGS2LMNA
SCHEMBL21362348 0.81 NPC1 (0.31) MAPTNPC1CSF1R
SCHEMBL21362290 0.79 PTGS2 (0.35) MAPTNPC1PTGS2LMNAUSP2
SCHEMBL21362324 0.79 NPC1 (0.40) MAPTNPC1FFAR4PTGS2GRM5
SCHEMBL21362326 0.75 NPC1 (0.40) MAPTNPC1FFAR4PTGS2GRM5
SCHEMBL21362371 0.71 NPC1 (0.48) MAPTNPC1FFAR4PTGS2GRM5
SCHEMBL21362292 0.69 NPC1 (0.50) MAPTNPC1PTGS2LMNAUSP2
SCHEMBL19389196 0.69 CHRNA7 (0.43) MAPTNPC1LMNAKCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190288223-A1 ORGANOMETALLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2019-09-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190288223-A1 ORGANOMETALLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME TPO, RPLP0, RPS10 MAPT 463/4885NPC1 4210/4885FFAR4 4593/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.